← Leaderboards
Linda A. Schuler
University Of Wisconsin Madison
$6,665,882
Attributed
$8,613,911
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $825.4K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,613,911 · 4
By mechanism
R01$8,613,911 · 4
Top collaborators
- Patricia J Keely5 shared
- Suzanne Marie Ponik5 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Susan M Paskewitz$21,462,467
- Glen S Kwon$5,558,269
- Patricia J Keely$12,114,445
- James D. Bangs$10,281,114
- David J Miller$7,086,459
Others in their field
Top investigators on “Prolactin”
- Susan E. Hankinson · University Of Massachusetts Amherst$28,528,655
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$10,682,303
- Charles V Clevenger · University Of Pennsylvania$7,339,531
- Hallgeir Rui · Henry M. Jackson Fdn For The Adv Mil/Med$7,223,758
- Sally A. Camper · University Of Michigan At Ann Arbor$6,828,197
- Betsy Lozoff · University Of Michigan At Ann Arbor$6,129,416
Research focus
ProlactinNeoplastic CellSamplingWomanHormonesMouse ModelImmunocompetentMalignant NeoplasmsTumorHormonalNeoplasm MetastasisSignal TransductionMalignant Breast NeoplasmMediator Of Activation ProteinCollagen FiberFibroblastsIn VivoExtracellular MatrixDensityEstrogen TherapyEstrogen Receptor PositiveAutomobile DrivingEstrogensEstrogen Receptors
Grant awards (30)
Matrix density promotes pro-tumorigenic hormone actions in breast cancer$458,881
R01 · FY2024 · CA · contact PI
Matrix density promotes pro-tumorigenic hormone actions in breast cancer$473,371
R01 · FY2023 · CA · contact PI
Matrix density promotes pro-tumorigenic hormone actions in breast cancer$473,371
R01 · FY2022 · CA · contact PI
Matrix density promotes pro-tumorigenic hormone actions in breast cancer$483,032
R01 · FY2021 · CA · contact PI
Matrix density promotes pro-tumorigenic hormone actions in breast cancer$481,515
R01 · FY2020 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$465,245
R01 · FY2018 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$465,245
R01 · FY2017 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$62,410
R01 · FY2017 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$465,245
R01 · FY2016 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$62,410
R01 · FY2016 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$480,984
R01 · FY2015 · CA · contact PI
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas$308,138
R01 · FY2015 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$36,265
R01 · FY2015 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$480,984
R01 · FY2014 · CA · contact PI
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas$298,894
R01 · FY2014 · CA · contact PI
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas$289,650
R01 · FY2013 · CA · contact PI
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas$308,138
R01 · FY2012 · CA · contact PI
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas$308,138
R01 · FY2011 · CA · contact PI
Endocytosis and trafficking of PRL receptor isoforms$211,346
R01 · FY2006 · DK · contact PI
Mammary Prolactin Production and Breast Cancer$254,625
R01 · FY2005 · CA
Endocytosis and trafficking of PRL receptor isoforms$216,433
R01 · FY2005 · DK
Mammary Prolactin Production and Breast Cancer$254,625
R01 · FY2004 · CA
Endocytosis and trafficking of PRL receptor isoforms$216,433
R01 · FY2004 · DK
Endocytosis and trafficking of PRL receptor isoforms$246,986
R01 · FY2003 · DK
Mammary Prolactin Production and Breast Cancer$237,691
R01 · FY2003 · CA
MAMMARY PROLACTIN PRODUCTION AND BREAST CANCER$48,034
R01 · FY2003 · CA
MAMMARY PROLACTIN PRODUCTION AND BREAST CANCER$231,044
R01 · FY2001 · CA
MAMMARY PROLACTIN PRODUCTION AND BREAST CANCER$36,000
R01 · FY2001 · CA
MAMMARY PROLACTIN PRODUCTION AND BREAST CANCER$222,778
R01 · FY2000 · CA
MAMMARY PROLACTIN PRODUCTION AND BREAST CANCER$36,000
R01 · FY2000 · CA